Case number 1:22-cv-00444
Merck Sharp & Dohme LLC v. Mankind Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 19, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. [16]. (nms) |
| Jul 19, 2022 | 15 | Proposed Consent Judgment (3) Docket Text: PROPOSED Consent Judgment between Plaintiff and Defendants Mankind Pharma Ltd. and Lifestar Pharma LLC, by Merck Sharp & Dohme LLC. (Joyce, Alexandra) Modified on 7/19/2022 (nms). |
| Jul 19, 2022 | 16 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT between Plaintiff and Defendants Lifestar Pharma LLC and Mankind Pharma Ltd.. Signed by Judge Richard G. Andrews on 7/19/2022. Associated Cases: 1:19-md-02902-RGA, 1:22-cv-00444-RGA(nms) |
| Jul 19, 2022 | 17 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326, 708. (Attachments: # (1) Consent Judgment)(nms) |
| Jul 19, 2022 | 17 | Consent Judgment (3) |
| Jul 5, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Lifestar Pharma LLC answer due 7/25/2022; Mankind Pharma Ltd. answer due 7/25/2022). Signed by Judge Richard G. Andrews on 7/5/2022. (nms) |
| Jul 5, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The notice filed at D.I. 13 has been removed from the docket as it was substantively duplicative of the notice at D.I. [12]. (nms) |
| Jul 5, 2022 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Adam V. Orlacchio and James G. Gorman, III on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Orlacchio, Adam) Modified on 7/5/2022 (nms). |
| Jul 5, 2022 | 14 | Stipulation (2) Docket Text: STIPULATION and [Proposed Order] to Extend Time, by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) Modified on 7/5/2022 (nms). |
| Jun 27, 2022 | 10 | Main Document (2) Docket Text: DECLARATION of Service of Mankind Pharma Ltd., by Merck Sharp & Dohme LLC. (Attachments: # (1) Exhibits A-B)(Silver, Daniel) Modified on 6/27/2022 (nms). |
| Jun 27, 2022 | 10 | Exhibit A-B (8) |
| Jun 27, 2022 | 11 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Merck Sharp & Dohme LLC. Lifestar Pharma LLC served on 6/17/2022, answer due 7/8/2022. (Silver, Daniel) |
| Jun 21, 2022 | 9 | Order (2) Docket Text: ORDER Granting (D.I. 55 in 21-cv-315-RGA; D.I. 8 in 22-cv-444-RGA; D.I. 670 in 19-md-2902-RGA) Unopposed Motion to Substitute Plaintiff and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/21/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA, 1:22-cv-00444-RGA(nms) |
| Jun 7, 2022 | 8 | Main Document (3) Docket Text: UNOPPOSED Motion to Substitute Plaintiff and Amend Case Caption - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) 7.1.1. Certification, # (2) Proposed Order)(Silver, Daniel) Modified on 6/7/2022 (nms). |
| Jun 7, 2022 | 8 | Rule 7.1.1. Certification (1) |
| Jun 7, 2022 | 8 | Text of Proposed Order (2) |
| Apr 29, 2022 | 7 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 6, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Apr 4, 2022 | N/A | Remark (0) Docket Text: Remark: MDL has been advised (mal) |
| Apr 4, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Lifestar Pharma LLC, Mankind Pharma Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3842311.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(mal) |
| Apr 4, 2022 | 1 | Exhibit A (18) |
| Apr 4, 2022 | 1 | Civil Cover Sheet (2) |
| Apr 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Apr 4, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 2/17/2022. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: No earlier than 8/17/2024. (mal) |
| Apr 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (mal) |
| Apr 4, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (mal) |
| Apr 4, 2022 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Apr 4, 2022 | 1 | Complaint* (1) |
